Search alternatives:
linear decrease » linear increase (Expand Search)
lower decrease » larger decrease (Expand Search), teer decrease (Expand Search), showed decreased (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
linear decrease » linear increase (Expand Search)
lower decrease » larger decrease (Expand Search), teer decrease (Expand Search), showed decreased (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
-
5861
Data Sheet 2_Exploring the role of neutrophils in inflammatory pain hypersensitivity via single-cell transcriptome profiling.xlsx
Published 2025“…</p>Results<p>scRNA-seq revealed a significant increase in neutrophils and a decrease in monocytes among CD11b<sup>+</sup> cells following surgery and CFA treatment. …”
-
5862
Table 1_Effect of Ebenatide on glycemic metabolism and body fat in patients with type 2 diabetes mellitus.docx
Published 2025“…</p>Results<p>The Ebenatide group showed significantly lower in hemoglobin A1c (HbA1c), mean blood glucose (MBG), time above range (TAR) and standard deviation (SD), along with improvement of time in range (TIR) at Week 24 and Week 52 compared to baseline (P<0.05). …”
-
5863
R project including metadata update.
Published 2025“…ASAP was found to be superior to RESL due to RESL’s adherence to the concept of the DNA barcoding gap. Moreover, we found that taxonomic misassignments, inconsistencies in BIN formation, and missing metadata also contribute significantly to unreliable identifications. …”
-
5864
Classes of errors and gaps in BOLD metadata.
Published 2025“…ASAP was found to be superior to RESL due to RESL’s adherence to the concept of the DNA barcoding gap. Moreover, we found that taxonomic misassignments, inconsistencies in BIN formation, and missing metadata also contribute significantly to unreliable identifications. …”
-
5865
Supplementary Material for: Endoscopic Anti-reflux Mucosal Interventions for Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis of Efficacy, Safety, and Compara...
Published 2025“…Results: Technical success was 100%, with a mean procedure time of 42.09 minutes. ARMIs significantly reduced the proportion of patients using PPI (RR=2.22-3.06; <3–24 months; P≤0.001) and improved GERD-Q, GERD-HRQL, and DeMeester scores through 36 months (P<0.05). …”
-
5866
Supplementary file 1_Clinical features of benign paroxysmal positional vertigo in the elderly.docx
Published 2025“…</p>Conclusion<p>Compared to the middle-aged BPPV group, elderly patients with BPPV exhibited a higher DHI score, increased fall rates, lower BBS scores, and lower rate maneuver, which had a more significant negative impact on daily life.…”
-
5867
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
5868
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
5869
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
5870
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
5871
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
5872
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
5873
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
5874
Table 1_Molecular hybridization modification improves the stability and immunomodulatory activity of TP5 peptide.docx
Published 2024“…The half-life of YTP in plasma is significantly longer than that of YW12D and TP5. YTP also displays an improved ability to protect the host from CTX-induced weight loss and thymus and spleen indices decrease than YW12D and TP5. …”
-
5875
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
5876
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
5877
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
5878
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
5879
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
5880
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”